NANOVIRICIDES, INC. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
NANOVIRICIDES, INC. (NNVC) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $11.92 thousand for the 12-month period ending 2019-06-30, per its 10-K filed 2021-10-12.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2021-10-12
- NANOVIRICIDES, INC. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2018-09-30 was $11.92K.
- NANOVIRICIDES, INC. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2019 was $11.92K.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|
| 2019-06-30 | $11.92K 10-K · filed 2021-10-12 | |
| 2018-09-30 | $11.92K 10-Q · filed 2020-06-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |